Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents

Jonathan M. Slezak, Melanie Mueller, George Ricaurte, Jonathan L. Katz

Research output: Contribution to journalArticle

Abstract

Amphetamine is a common therapeutic agent for alleviating the core symptoms associated with attention-deficit hyperactivity disorder (ADHD) in children and adults. The current study used a translational model of attention, the five-choice serial reaction time (5-CSRT) procedure with rats, to examine the time-course effects of d-amphetamine. Effects of different dosages of d-amphetamine were related to drug-plasma concentrations, fashioned after comprehensive pharmacokinetic/pharmacodynamic assessments that have been employed in clinical investigations. We sought to determine whether acute drug-plasma concentrations that enhance performance in the 5-CSRT procedure are similar to those found to be therapeutic in patients diagnosed with ADHD. Results from the pharmacokinetic/pharmacodynamic assessment indicate that d-amphetamine plasma concentrations associated with improved performance on the 5-CSRT procedure overlap with those that have been reported to be therapeutic in clinical trials. The current findings suggest that the 5-CSRT procedure may be a useful preclinical model for predicting the utility of novel ADHD therapeutics and their effective concentrations.

Original languageEnglish (US)
Pages (from-to)551-556
Number of pages6
JournalBehavioural Pharmacology
Volume29
Issue number6
DOIs
StatePublished - Sep 1 2018

Fingerprint

Dextroamphetamine
Rodentia
Attention Deficit Disorder with Hyperactivity
Pharmacokinetics
Amphetamine
Therapeutics
Pharmaceutical Preparations
Reaction Time
Clinical Trials

Keywords

  • attention
  • attention-deficit hyperactivity disorder
  • d-amphetamine
  • five-choice serial reaction time
  • pharmacokinetics
  • rat
  • time course

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents. / Slezak, Jonathan M.; Mueller, Melanie; Ricaurte, George; Katz, Jonathan L.

In: Behavioural Pharmacology, Vol. 29, No. 6, 01.09.2018, p. 551-556.

Research output: Contribution to journalArticle

Slezak, Jonathan M. ; Mueller, Melanie ; Ricaurte, George ; Katz, Jonathan L. / Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents. In: Behavioural Pharmacology. 2018 ; Vol. 29, No. 6. pp. 551-556.
@article{cf400cfa6ab64b2bbe6f80c06bda0063,
title = "Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents",
abstract = "Amphetamine is a common therapeutic agent for alleviating the core symptoms associated with attention-deficit hyperactivity disorder (ADHD) in children and adults. The current study used a translational model of attention, the five-choice serial reaction time (5-CSRT) procedure with rats, to examine the time-course effects of d-amphetamine. Effects of different dosages of d-amphetamine were related to drug-plasma concentrations, fashioned after comprehensive pharmacokinetic/pharmacodynamic assessments that have been employed in clinical investigations. We sought to determine whether acute drug-plasma concentrations that enhance performance in the 5-CSRT procedure are similar to those found to be therapeutic in patients diagnosed with ADHD. Results from the pharmacokinetic/pharmacodynamic assessment indicate that d-amphetamine plasma concentrations associated with improved performance on the 5-CSRT procedure overlap with those that have been reported to be therapeutic in clinical trials. The current findings suggest that the 5-CSRT procedure may be a useful preclinical model for predicting the utility of novel ADHD therapeutics and their effective concentrations.",
keywords = "attention, attention-deficit hyperactivity disorder, d-amphetamine, five-choice serial reaction time, pharmacokinetics, rat, time course",
author = "Slezak, {Jonathan M.} and Melanie Mueller and George Ricaurte and Katz, {Jonathan L.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1097/FBP.0000000000000409",
language = "English (US)",
volume = "29",
pages = "551--556",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents

AU - Slezak, Jonathan M.

AU - Mueller, Melanie

AU - Ricaurte, George

AU - Katz, Jonathan L.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Amphetamine is a common therapeutic agent for alleviating the core symptoms associated with attention-deficit hyperactivity disorder (ADHD) in children and adults. The current study used a translational model of attention, the five-choice serial reaction time (5-CSRT) procedure with rats, to examine the time-course effects of d-amphetamine. Effects of different dosages of d-amphetamine were related to drug-plasma concentrations, fashioned after comprehensive pharmacokinetic/pharmacodynamic assessments that have been employed in clinical investigations. We sought to determine whether acute drug-plasma concentrations that enhance performance in the 5-CSRT procedure are similar to those found to be therapeutic in patients diagnosed with ADHD. Results from the pharmacokinetic/pharmacodynamic assessment indicate that d-amphetamine plasma concentrations associated with improved performance on the 5-CSRT procedure overlap with those that have been reported to be therapeutic in clinical trials. The current findings suggest that the 5-CSRT procedure may be a useful preclinical model for predicting the utility of novel ADHD therapeutics and their effective concentrations.

AB - Amphetamine is a common therapeutic agent for alleviating the core symptoms associated with attention-deficit hyperactivity disorder (ADHD) in children and adults. The current study used a translational model of attention, the five-choice serial reaction time (5-CSRT) procedure with rats, to examine the time-course effects of d-amphetamine. Effects of different dosages of d-amphetamine were related to drug-plasma concentrations, fashioned after comprehensive pharmacokinetic/pharmacodynamic assessments that have been employed in clinical investigations. We sought to determine whether acute drug-plasma concentrations that enhance performance in the 5-CSRT procedure are similar to those found to be therapeutic in patients diagnosed with ADHD. Results from the pharmacokinetic/pharmacodynamic assessment indicate that d-amphetamine plasma concentrations associated with improved performance on the 5-CSRT procedure overlap with those that have been reported to be therapeutic in clinical trials. The current findings suggest that the 5-CSRT procedure may be a useful preclinical model for predicting the utility of novel ADHD therapeutics and their effective concentrations.

KW - attention

KW - attention-deficit hyperactivity disorder

KW - d-amphetamine

KW - five-choice serial reaction time

KW - pharmacokinetics

KW - rat

KW - time course

UR - http://www.scopus.com/inward/record.url?scp=85051275340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051275340&partnerID=8YFLogxK

U2 - 10.1097/FBP.0000000000000409

DO - 10.1097/FBP.0000000000000409

M3 - Article

C2 - 29864032

AN - SCOPUS:85051275340

VL - 29

SP - 551

EP - 556

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 6

ER -